Early recognition of clinical presentations consistent with the deliberate release of a Category A bioterrorism agent is essential for rapid patient isolation, public health notification, and outbreak containment. The ability of UK clinicians-in-training to recognise these syndromes had not been previously assessed. This pilot study sought to evaluate how well final-year UK medical students identify syndromes associated with Category A agents compared with clinically overlapping non-bioterrorism presentations.
This was a pilot cross-sectional online survey administered to final-year UK medical students. The survey used single-best-answer clinical vignettes to depict two vignette types: syndromes associated with Category A bioterrorism agents (BT vignettes) and clinically overlapping non-bioterrorism syndromes (NBT vignettes). Participant performance was summarised as the proportion of vignettes correctly identified. The primary analysis compared within-participant performance on BT versus NBT vignettes.
Twenty-five participants completed the survey. Overall, participants performed worse on BT vignettes (mean proportion correct = 0.55) than on NBT vignettes (mean = 0.81). The within-participant difference in performance was −0.26 with a 95% confidence interval of −0.35 to −0.18. This difference was statistically significant: t(24) = −6.33, p < 0.001, with a large effect size (Cohen’s dz = −1.27).
Recognition rates for individual Category A–associated syndromes varied substantially:
Botulism was recognised by most participants (96.0%).
Ebola virus disease was recognised by the majority (88.0%).
Anthrax was recognised by 40.0% of participants.
Pneumonic plague was recognised by 28.0% of participants.
Smallpox was recognised by 24.0% of participants.
These findings show strong recognition for some high-profile agents but substantial gaps for others.
Performance was compared within participants between BT and NBT vignettes. The mean difference of −0.26 represents a lower correct identification rate for Category A syndromes versus clinically similar non-bioterrorism presentations. The provided t-test (paired) result and confidence interval indicate that this deficit is both statistically significant and large in magnitude in this sample.
In this pilot sample of final-year UK medical students, the ability to identify syndromes attributable to Category A agents was meaningfully poorer than the ability to recognise clinically overlapping non-bioterrorism syndromes. High recognition rates for botulism and Ebola suggest that some agents are readily identified, while low rates for anthrax, pneumonic plague, and smallpox reveal notable diagnostic gaps. The authors interpret these results as the first UK evidence of a substantial diagnostic deficit among near-graduation medical students for Category A bioterrorism syndromes.
Given the importance of early detection for isolation and public health response, these pilot findings point to potential educational and preparedness implications for undergraduate medical curricula and clinical training. The source article reports only the pilot data and does not specify subsequent curricular interventions or policy recommendations.
This study is a pilot with a small sample size (n = 25), which limits generalisability. The report does not provide demographic breakdowns of participants, details of vignette content or number, response rates, recruitment methods, or whether the sample was representative of all UK medical schools. Because the source is the sole information provided here, any additional methodological specifics were not reported in the source and therefore are not described.
The authors report ethical approval from the University of Cambridge’s Institute of Technology and Humanity Research Ethics Committee (ITH-REC reference: 25.3) dated 09 December 2025. The authors declared no competing interests. The source states that all data produced in the study are available upon reasonable request to the authors.
This pilot cross-sectional survey of final-year UK medical students identified significantly lower recognition of Category A bioterrorism agent syndromes compared with clinically overlapping non-bioterrorism syndromes, with marked variability across specific agents. The findings provide initial UK evidence of a diagnostic deficit among soon-to-graduate medical students for several Category A agents. The source does not report follow-up studies, educational interventions, or wider sampling; these would be needed to confirm and act on the pilot findings.